Rheumatoid arthritis

· SICS Editore
E-knjiga
57
str.
Ispunjava uvjete
Ocjene i recenzije nisu potvrđene  Saznajte više

O ovoj e-knjizi

The aim is to induce early clinical remission with prompt diagnosis and timely introduction of disease-modifying antirheumatic drugs (DMARDs). Diagnosis is primarily based on history and examination of the joints. Inflammatory laboratory markers (CRP and ESR) may be normal. The presence of anti-cyclic citrullinated peptide (anti-CCP) antibodies is more specific for rheumatoid arthritis (RA) than the presence of rheumatoid factor. If RA is strongly suspected (polyarthritis) the patient must be referred to specialist care without delay. The combination of several drugs is more effective than monotherapy. Over half of patients with early RA are rendered asymptomatic with combination therapy (methotrexate + sulfasalazine + hydroxychloroquine + low-dose prednisolone) . If sufficient response is not achieved with the above-mentioned therapy, treatment with biological agents (biological response modifiers, biologics) is started. Glucocorticoids should not be started in primary care since they may delay diagnosis and hamper the assessment of disease severity.

Ocijenite ovu e-knjigu

Recite nam što mislite.

Informacije o čitanju

Pametni telefoni i tableti
Instalirajte aplikaciju Google Play knjige za Android i iPad/iPhone. Automatski se sinkronizira s vašim računom i omogućuje vam da čitate online ili offline gdje god bili.
Prijenosna i stolna računala
Audioknjige kupljene na Google Playu možete slušati pomoću web-preglednika na računalu.
Elektronički čitači i ostali uređaji
Za čitanje na uređajima s elektroničkom tintom, kao što su Kobo e-čitači, trebate preuzeti datoteku i prenijeti je na svoj uređaj. Slijedite detaljne upute u centru za pomoć za prijenos datoteka na podržane e-čitače.